Почетна › Akutna mijeloidna leukemija › Северна Каролина › Durham
Kliničke studije za Akutna mijeloidna leukemija u gradu Durham, NC
34 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Durham i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Duke University Medical Center, Durham
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 ми удаљено
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Duke University Medical Center, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Durham VA Medical Center, Durham
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Тражи се учесникФаза 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Тражи се учесникФаза 1/2
- Duke Cancer Center, Durham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Duke University Medical Center, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Тражи се учесникОпсервациона студија
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ми удаљено
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Тражи се учесникФаза 2
- Duke University Medical Center, Durham
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Тражи се учесникФаза 1/2
- Research Site, Durham
- Research Site, Chapel Hill · 10 ми удаљено
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Тражи се учесникФаза 3
- Clinical Trial Site, Chapel Hill · 10 ми удаљено
A Study of Revumenib and Mezigdomide in People With Leukemia
Тражи се учесникФаза 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 ми удаљено
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Тражи се учесникФаза 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Тражи се учесникФаза 1/2
- Duke University Medical Center, Durham
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Тражи се учесникФаза 2/3
- Duke University, Durham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Тражи се учесникФаза 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 ми удаљено
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Тражи се учесникФаза 3
- US-Chapel Hill-UNCNORTHCAROLINA, Chapel Hill · 10 ми удаљено
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Тражи се учесникФаза 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Тражи се учесникФаза 1
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Тражи се учесникФаза 1
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Тражи се учесникФаза 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Тражи се учесник
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Тражи се учесникОпсервациона студија
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Registry of Older Patients With Cancer
Тражи се учесникОпсервациона студија
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 ми удаљено
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Тражи се учесникФаза 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
Тражи се учесникФаза 1
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Тражи се учесникФаза 1
- University of North Carolina, Chapel Hill · 10 ми удаљено
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Тражи се учесникФаза 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · 10 ми удаљено
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Тражи се учесникФаза 2
- University of North Carolina, Chapel Hill · 10 ми удаљено
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Тражи се учесникФаза 1
- Duke Blood Cancer Center, Durham
Novel Digital Application for Patients With Acute Leukemia
Тражи се учесник
- Duke University, Durham
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Тражи се учесникФаза 1/2
- Duke University Medical Center, Durham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Тражи се учесникЗдраве особе су добродошле
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Studije za Akutna mijeloidna leukemija u drugim gradovima
- Houston, TX88 студија
- New York City, NY51 студија
- Boston, MA44 студија
- Baldwin Park, CA41 студија
- Seattle, WA40 студија
- Columbus, OH34 студија
- Philadelphia, PA33 студија
- Atlanta, GA30 студија
- Tampa, FL30 студија
- Chicago, IL27 студија
- Los Angeles, CA25 студија
- Portland, OR24 студија
Ostale studije u gradu Durham
- Рак дојке63 студија
- Рак (све врсте)61 студија
- Немалоклетни карцином плућа42 студија
- Многи мијелом36 студија
- Рак плућа33 студија
- Метастатски карцином33 студија
- Рак простате32 студија
- Колоректални карцином30 студија
- Рак јајника28 студија
- Hronična limfocitna leukemija28 студија
- Затајење срца25 студија
- Рак панкреаса24 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.